Abstract

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol

Author(s): McKettrick Greg, Yoch Doug

Issue: Jan/Feb 2021 - Volume 25, Number 1

Page(s): 18-23

Download in electronic PDF format for $75

Abstract

Although prostatectomy and radiotherapy yield excellent- long term survival rates for men with prostate cancer, adverse effects (erectile dysfunction and/or urinary incontinence with subsequent undesired lifestyle modifications, anxiety about the loss of intimacy, negative self-perception, and the effects of such stressors on work performance and family relationships) frequently afflict patients who have undergone these procedures. Surgeons who specialize in the treatment of prostate cancer are dedicated to ensuring the optimal clinical result but often do not provide information about the likelihood of experiencing those sequelae or the additional support and aftercare necessary to ensure posttreatment sexual and urologic function to their patients’ satisfaction. In response to the needs of these underserved patients, the authors designed the Stanley Prostate-cancer Treatment Protocol for erectile dysfunction and urinary incontinence. The goal of the Stanley Protocol is to achieve an improved outcome after surgery or radiation therapy for prostate cancer via comprehensive therapy, patient monitoring, and detailed training. Each Protocol program is customized to address the individual patient’s needs as he attains his desired level of sexual function and urinary control. Feedback consistently indicates that patients who participate in the Stanley Protocol achieve those goals, and the authors suggest that this program can be incorporated into any compounding practice to provide the same result. In this article, the most common questions that compounders ask about the Stanley Protocol are answered, an outline of that therapeutic guideline is presented, and formulations proven to optimize the outcome of prescribed treatment are provided.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2007 Pg. 122-124	Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Author(s): Fields Shannon W
May/Jun 2004 Pg. 231-235	Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Author(s): Trissel Lawrence A, Zhang Yanping
Mar/Apr 2010 Pg. 105-107	Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? Author(s): Williams LaVonn A
Sep/Oct 2012 Pg. 369-375	Medical Therapy for Acquired Urinary Incontinence in Dogs Author(s): Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Sep/Oct 2017 Pg. 358-362	Compounding Opportunities in Urology Author(s): Biundo Bruce
Jul/Aug 2002 Pg. 255-256	Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Author(s): Mason Dave
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
May/Jun 2004 Pg. 175-178	Andropause: New Perspectives Author(s): Biundo Bruce
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Jan/Feb 2013 Pg. 28-38	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 6-14	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
Mar/Apr 1999 Pg. 85-87	Complementary Medical Approaches to Benign Prostatic Hyperplasia Author(s): Meletis Chris D
Mar/Apr 1999 Pg. 80-83	Male Impotency and the Compounding Pharmacist Author(s): Preckshot John
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Jul/Aug 2009 Pg. 276-279	Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Author(s): Biundo Bruce
Mar/Apr 2010 Pg. 100-104	Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Author(s): Biundo Bruce